Mizuho Medy Co.,Ltd.
4595
Rank in Stocks
#16578
Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd.... Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd. specializes in the research, development, production, and distribution of in-vitro diagnostic solutions, complemented by scientific and technical information services. While its primary operations are in Japan, the company maintains an international presence through import and export activities, extending its reach to countries including the United States, Belgium, Finland, the Netherlands, Taiwan, and Thailand. Its extensive product lineup includes a wide array of immunoassay test kits designed for detecting pathogens such as influenza viruses, RS virus, human metapneumovirus, Streptococcus pneumoniae, Legionella, Mycoplasma pneumoniae, adenovirus, rotavirus, norovirus, and Group A streptococcus. Additionally, Mizuho Medy offers kits for pregnancy, ovulation, and fecal occult blood screening. The company also provides advanced tools like gene analysis instruments and specialized diagnostic kits for SARS-CoV-2 detection and Mycoplasma pneumoniae nucleic acid analysis.
Share Price
$10.75
Last synced: 2026-11-13
Market Cap
$204.76M
Change (1 day)
-1.67%
Change (1 year)
1.92%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Mizuho Medy Co.,Ltd. (4595)
Category
Healthcare
Operating Margin for Mizuho Medy Co.,Ltd. (4595)
Operating Margin as of November 2026 TTM: 40.09%
According to Mizuho Medy Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is 40.09%. At the end of 2025 the company had an operating margin of 41.27%.
Operating Margin history for Mizuho Medy Co.,Ltd. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 40.09% | -2.86% |
| 2025 | 41.27% | -4.07% |
| 2024 | 43.02% | -8.23% |
| 2023 | 46.88% | -25.78% |
| 2022 | 63.16% | 21.51% |
| 2021 | 51.98% | 425.05% |
| 2020 | 9.90% | -42.74% |
| 2019 | 17.29% | -9.00% |
| 2018 | 19.00% | 25.66% |
| 2017 | 15.12% | 41.71% |
| 2016 | 10.67% | 12.20% |
| 2015 | 9.51% | -18.23% |
| 2014 | 11.63% | 88.80% |
| 2013 | 6.16% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.69% | -99.51% |
DE
|
|
| 19.68% | -99.51% |
DE
|
|
| 13.26% | -99.67% |
JP
|
|
| 17.08% | -99.57% |
CH
|
|
| 10.53% | -99.74% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Mizuho Medy Co.,Ltd.'s operating margin
What is Mizuho Medy Co.,Ltd.'s operating margin?
Mizuho Medy Co.,Ltd.'s operating margin is 40.09%, as of Nov 2026.
What was Mizuho Medy Co.,Ltd.'s operating margin in 2025?
In 2025, Mizuho Medy Co.,Ltd.'s operating margin was 41.27%, compared with 43.02% in 2024.
How has Mizuho Medy Co.,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Mizuho Medy Co.,Ltd.'s operating margin was highest in 2022 (63.16%) and lowest in 2020 (9.90%).
How does Mizuho Medy Co.,Ltd.'s operating margin compare with similar companies?
Mizuho Medy Co.,Ltd.'s operating margin (40.09%) is higher than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.